The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 21, 2006

Filed:

Feb. 14, 2003
Applicants:

Eric Jon Jacobsen, Richland, MI (US);

Jason K. Myers, Kalamazoo, MI (US);

Daniel Patrick Walker, Kalamazoo, MI (US);

Donn G. Wishka, Kalamazoo, MI (US);

Steven Charles Reitz, Toledo, OH (US);

David W. Piotrowski, Portage, MI (US);

Brad A. Acker, Kalamazoo, MI (US);

Vincent E. Groppi, Jr., Kalamazoo, MI (US);

Inventors:

Eric Jon Jacobsen, Richland, MI (US);

Jason K. Myers, Kalamazoo, MI (US);

Daniel Patrick Walker, Kalamazoo, MI (US);

Donn G. Wishka, Kalamazoo, MI (US);

Steven Charles Reitz, Toledo, OH (US);

David W. Piotrowski, Portage, MI (US);

Brad A. Acker, Kalamazoo, MI (US);

Vincent E. Groppi, Jr., Kalamazoo, MI (US);

Assignee:

Pfizer Inc., New York, NY (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/55 (2006.01); A61K 31/506 (2006.01); A61K 31/439 (2006.01); C07D 471/08 (2006.01); C07D 487/08 (2006.01);
U.S. Cl.
CPC ...
Abstract

The invention provides compounds of Formula I:wherein Azabicyclo isW is a six-membered heterocyclic ring system having 1–2 nitrogen atoms or a 10-membered bicyclic-six-six-fused-ring system having up to two nitrogen atoms within either or both rings, provided that no nitrogen is at a bridge of the bicyclic-six-six-fused-ring system, and further having 1–2 substitutents independently selected from R. These compounds may be in the form of pharmaceutical salts or compositions, may be in pure enantiomeric form or racemic mixtures, and are useful in pharmaceuticals to treat diseases or conditions in which α7 is known to be involved.


Find Patent Forward Citations

Loading…